CNS Pharmaceuticals Inc
NASDAQ:CNSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
P
|
PICC Property and Casualty Co Ltd
SWB:PJC
|
CN |
|
P
|
PayPal Holdings Inc
F:2PP
|
US |
|
N
|
Nissan Chemical Corp
SWB:NSC
|
JP |
|
P
|
Pool Corp
F:SP1
|
US |
|
C
|
Copart Inc
F:CO6
|
US |
|
Asia Vital Components Co Ltd
OTC:AVMPF
|
TW |
|
C
|
Capital One Financial Corp
DUS:CFX
|
US |
|
C
|
Crown Holdings Inc
SWB:CWN
|
US |
|
N
|
Newmont Corporation
TSX:NGT
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
OTC:PUODY
|
MX |
|
CMOC Group Ltd
OTC:CMCLY
|
CN |
|
Fuyao Glass Industry Group Co Ltd
SSE:600660
|
CN |
Bankruptcy Probability
CNS Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CNS Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
7.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
284.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CNS Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CNS Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.